New diabetes clinical trial: Association of Gene Polymorphism With Susceptibility to T2DM and the Therapeutic Responses to Exenatide in Chinese Patients With T2DM

Published on: February 12, 2024 at 11:00PM
Conditions: Type 2 Diabetes Mellitus; Susceptibility, Genetic
Interventions: Drug: GLP-1 receptor agonist; Drug: responders group and nonresponders group
Sponsors: The Affiliated Hospital of Xuzhou Medical University
Recruiting
https://ift.tt/mVfrJdH